Wagner Wealth Management (South Carolina)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,009
Closed -$252K 259
2024
Q2
$252K Buy
9,009
+824
+10% +$22.7K 0.08% 112
2024
Q1
$227K Buy
+8,185
New +$227K 0.07% 120
2023
Q2
Sell
-5,825
Closed -$238K 230
2023
Q1
$238K Sell
5,825
-14,513
-71% -$627K 0.11% 104
2022
Q4
$1.04M Sell
20,338
-4,933
-20% -$237K 0.64% 44
2022
Q3
$1.11M Buy
25,271
+515
+2% +$25K 0.82% 31
2022
Q2
$1.3M Buy
24,756
+219
+0.9% +$11.2K 1.03% 29
2022
Q1
$1.27M Sell
24,537
-12,138
-33% -$630K 0.89% 24
2021
Q4
$2.17M Buy
36,675
+908
+3% +$45K 1.66% 12
2021
Q3
$1.56M Buy
35,767
+86
+0.2% +$3.81K 1.25% 19
2021
Q2
$1.4M Buy
35,681
+10,701
+43% +$416K 1% 23
2021
Q1
$905K Buy
24,980
+4,827
+24% +$171K 0.71% 38
2020
Q4
$742K Buy
+20,153
New +$739K 0.7% 45
2018
Q3
$264K Buy
6,315
+88
+1% +$3.39K 0.18% 108
2018
Q2
$214K Buy
6,227
+963
+18% +$32.9K 0.15% 109
2018
Q1
$177K Sell
5,264
-422
-7% -$14.5K 0.13% 113
2017
Q4
$197K Buy
+5,686
New +$194K 0.15% 110

Other funds holding PFE

Wagner Wealth Management (South Carolina)'s PFE Position: Q3 2024 in Review

Wagner Wealth Management (South Carolina) sold out of Pfizer (PFE) in Q3 2024, closing a stake of 9,009 shares — an estimated $252K sold.

Wagner Wealth Management (South Carolina) first reported a position in PFE in Q4 2017 and held it in 16 quarters. The position peaked at $2.17M in Q4 2021. 2,913 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Wagner Wealth Management (South Carolina) reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 9,009 Pfizer shares in Q3 2024, an estimated $252K.
  • Wagner Wealth Management (South Carolina) first reported a position in Pfizer in Q4 2017 and held it in 16 quarters.
  • Wagner Wealth Management (South Carolina)'s Pfizer position peaked at $2.17M in Q4 2021.
  • 2,913 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2024, filed 11 Oct 2024.